Ultralife Corporation
ULBI
$4.13
-$0.15-3.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 22.86% | -16.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.86% | -16.96% | |||
| Cost of Revenue | 23.10% | -14.03% | |||
| Gross Profit | 22.08% | -24.92% | |||
| SG&A Expenses | 19.60% | 3.03% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.03% | -10.58% | |||
| Operating Income | 60.84% | -80.57% | |||
| Income Before Tax | 40.23% | -90.82% | |||
| Income Tax Expenses | 254.05% | -91.32% | |||
| Earnings from Continuing Operations | -16.49% | -90.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -85.71% | 12.50% | |||
| Net Income | -24.81% | -91.31% | |||
| EBIT | 60.84% | -80.57% | |||
| EBITDA | 36.92% | -64.42% | |||
| EPS Basic | -24.52% | -91.35% | |||
| Normalized Basic EPS | -67.76% | -85.10% | |||
| EPS Diluted | -31.61% | -91.35% | |||
| Normalized Diluted EPS | -67.77% | -85.08% | |||
| Average Basic Shares Outstanding | 0.02% | 0.34% | |||
| Average Diluted Shares Outstanding | -0.66% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||